[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100322333":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":15,"centralContacts":20,"locations":25,"responsibleParty":40,"collaborators":42,"id":50,"slug":51,"hasResults":52,"nctId":53,"briefTitle":54,"officialTitle":55,"acronym":7,"eligibilityCriteria":56,"healthyVolunteers":52,"sex":57,"minAge":58,"maxAge":59,"enrollmentInfo":60,"targetDuration":7,"studyType":63,"phases":7,"briefSummary":64,"conditions":65,"keywords":67,"overallStatus":28,"whyStopped":7,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":81},{"fullName":5,"class":6},"Norwegian University of Science and Technology","OTHER",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":13},"DRUG","Gabapentin","Patients are tested for their normal prescription gabapentin medication",[14],"Neurontin",[16],{"name":17,"affiliation":18,"role":19},"Magnus Strømmen, MSc","St. Olavs Hospital","PRINCIPAL_INVESTIGATOR",[21],{"name":17,"role":22,"phone":23,"phoneExt":7,"email":24},"CONTACT","0047 72829970","magnus.strommen@stolav.no",[26],{"facility":27,"status":28,"city":29,"state":7,"zip":7,"country":30,"countryCode":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"St. Olavs University Hospital","RECRUITING","Trondheim","Norway","NO",{"type":33,"coordinates":34},"Point",[35,36],10.39506,63.43049,{"lat":36,"lon":35},[39],{"name":17,"role":22,"phone":7,"phoneExt":7,"email":7},{"type":41,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR",[43,44,46,48],{"name":18,"class":6},{"name":45,"class":6},"Volvat Medisinsk Senter Stokkan",{"name":47,"class":6},"Namsos Hospital",{"name":49,"class":6},"Alesund Hospital","100322333","bariatric-surgery-and-pharmacokinetics-of-gabapentin-100322333",false,"NCT03476538","Bariatric Surgery and Pharmacokinetics of Gabapentin","Bariatric Surgery and Pharmacokinetics Gabapentin: BAR-MEDS Gabapentin","Inclusion Criteria:\n\n* Preparing to undergo gastric bypass or sleeve gastrectomy in Central Norway\n* Being a Norwegian citizen\n\nExclusion Criteria:\n\n* Having previously undergone resections in the GI-tract","ALL","18 Years","70 Years",{"count":61,"type":62},12,"ESTIMATED","OBSERVATIONAL","Changes to gastric pH, gastric emptying time, gastrointestinal transit-time or the pre-systemic metabolizing effect of enzymes secreted in the mucosa may all alter the pharmacokinetics of medicines. These factors are potentially influenced by bariatric surgery. Little is so far known about how gastric bypass and sleeve gastrectomy impacts the biological availability of medication. In this study the pharmacokinetic effects of bariatric surgery on gabapentin are investigated.",[66],"Obesity, Morbid",[68,69,70,71,11],"Bariatric surgery","Gastrointestinal tract","Biological availability","Pharmacokinetics","2025-06-05",{"date":74,"type":75},"2025-06-06","ACTUAL",{"date":77,"type":75},"2016-11-02",{"date":79,"type":62},"2026-10",{"name":5,"class":6},1]